There is "little, if any, clinical reason" to use angiotensin-converting enzyme (ACE) inhibitors for the treatment of hypertension or other cardiovascular indications because angiotensin receptor ...

These include thiazide diuretics, ACE inhibitors, angiotensin II receptor blockers (often called ARBs), dihydropyridine calcium channel blockers, and non‑dihydropyridine calcium channel blockers. Each ...

Research has shown that angiotensin converting enzyme (ACE) inhibitors help manage diabetic nephropathy-related issues. They can also slow the progression of diabetic nephropathy in some people.

Patients with heart failure who start taking sacubitril/valsartan (Entresto; Novartis) do not appear to have a greater risk of angioedema than do those who opt for an ACE inhibitor or ARB instead, an ...

A new clinical decision support tool for primary care providers (PCPs) led to a modest improvement in reinitiation of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers ...